We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current FLGT market cap is 629.95M. The company's latest EPS is USD -5.6346 and P/E is -3.73.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 105.66M | 67.7M | 66.17M | 67.85M | 84.69M |
| Operating Income | 352k | -36.55M | -24.82M | -19.8M | 214k |
| Net Income | 1.72M | -25.31M | -15.34M | -11.23M | -13.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.53M | 421.71M | 992.58M | 618.97M | 289.21M |
| Operating Income | -428k | 290.16M | 679.69M | 178.53M | -195.53M |
| Net Income | -411k | 214.31M | 507.37M | 141.92M | -167.83M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.41B | 1.39B | 1.38B | 1.35B | 1.36B |
| Total Liabilities | 124.39M | 116.18M | 107.85M | 91.25M | 96.56M |
| Total Equity | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 88.76M | 700.46M | 1.28B | 1.39B | 1.24B |
| Total Liabilities | 5.98M | 131.07M | 112.84M | 116.18M | 102.04M |
| Total Equity | 82.78M | 569.39M | 1.17B | 1.27B | 1.13B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 220.31M | 253.52M | -7.91M | 1.83M | 12.07M |
| Investing | -168.72M | -261.31M | -4.35M | -5.45M | 14.63M |
| Financing | -47.55M | -77.14M | -1.1M | -17.36M | -21.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.52M | 140.63M | 538.58M | 253.52M | 27M |
| Investing | -29.05M | -326.44M | -546.55M | -261.31M | 38.9M |
| Financing | 28.78M | 261.25M | 85.41M | -77.14M | -47.79M |
| Market Cap | 629.95M |
| Price to Earnings Ratio | -3.73 |
| Price to Sales Ratio | 2.16 |
| Price to Cash Ratio | 6.42 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 29.78M |
| Average Volume (1 week) | 172.9k |
| Average Volume (1 Month) | 162.7k |
| 52 Week Change | -28.79% |
| 52 Week High | 44.09 |
| 52 Week Low | 19.88 |
| Spread (Intraday) | 0.02 (0.09%) |
| Company Name | Fulgent Genetics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.fulgentgenetics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
